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1  | INTRODUC TION
Laparoscopic donor nephrectomy (LDN) is the gold standard ap‐
proach for living‐donor kidney procurement. When compared to 
open donor nephrectomy, LDN is associated with less postoperative 
pain, faster recovery, shorter length of hospital stays, quicker return 
to normal daily activities, and a better cosmetic result.1 Yet, some 
long‐term donor outcomes after LDN, such as chronic postsurgical 
pain (CPSP), seem to be an underexposed topic. CPSP is defined by 
the International Association for the Study of Pain (IASP) as pain that 
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Chronic postsurgical pain (CPSP) following laparoscopic donor nephrectomy (LDN) is 
a disregarded topic. In this cross‐sectional study, all consecutive patients who under‐
went	an	LDN	at	the	Radboud	University	Medical	Center	(Radboudumc;	2003‐2016)	
were	approached	for	participation.	Five	hundred	twelve	living	kidney	donors	were	
included	 and	 asked	 to	 complete	 two	 questionnaires,	 including	 the	 McGill	 Pain	
Questionnaire	and	the	RAND	Short	Form‐36	Health	Status	Inventory	(RAND	SF‐36)	
regarding their health‐related quality of life (HRQoL). The mean prevalence of CPSP 
following LDN was 5.7%, with a mean follow‐up time of 6 years. Possible predictors 
of CPSP following LDN are severe early postoperative pain, previous abdominal sur‐
gery,	 and	preexisting	backache.	The	RAND	SF‐36	 revealed	an	 impaired	HRQoL	 in	
patients with CPSP when compared to patients without CPSP. In conclusion, this 
study	revealed	that	the	prevalence	of	CPSP	following	LDN	is	substantial.	Given	the	
possible association between the presence of CPSP and impaired HRQoL scores, liv‐
ing kidney donors should be well informed in the preoperative phase about the risk 
of CPSP.
K E Y W O R D S
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donation, kidney transplantation, kidney transplantation/nephrology, living donor, patient 
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develops after a surgical procedure and persists for at least 3 months 
after surgery, where all other causes of pain (eg, infection, recurring 
malignancy) or preexisting pain problems are excluded.2‐4 Possible 
pathologic factors leading to CPSP include inflammation, tissue and 
nerve damage, and altered central pain processing.5,6 Well‐known 
preoperative and postoperative risk factors are preoperative pain, 
early postoperative pain, previous surgery, psychological factors or 
disorders, patient characteristics (ie, younger age and female gen‐
der), comorbidities, and alterations in central pain processing.5,6 In 
addition the surgical technique can influence the development of 
CPSP, which is possibly related to the extent of intraoperative nerve 
injury and adhesion formation. A laparoscopic technique might 
reduce intraoperative nerve damage; however, the literature on 
CPSP following laparoscopic vs open procedures is inconsistent.6 
Gerbershagen	 and	 colleagues	 described	 an	 incidence	of	CPSP	 fol‐
lowing open nephrectomy (for benign and malignant renal disease) 
of 28.6% and 8.6%, after 3 and 6 months, respectively.7 Another 
study by Alper et al8 compared the incidence of CPSP following open 
vs laparoscopic nephrectomy for renal cell carcinoma. Two months 
after surgery they observed postsurgical pain in 16% of the patients 
who underwent an open procedure, and in 11% of the patients who 
underwent a laparoscopic procedure. After 6 months, only one pa‐
tient in both the open nephrectomy group and the laparoscopic 
nephrectomy group reported CPSP (4% and 3.7%, respectively). 
Accordingly, they stated that the risk of developing CPSP after open 
or laparoscopic tumor nephrectomy is comparable. A small cohort 
study, performed by Owen and colleagues,9 assessed the incidence 
of CPSP following open donor nephrectomy. After a follow‐up period 
of 3 months, 33% of 81 participants reported the presence of CPSP 
following their donor nephrectomy. Wolf and colleagues compared 
the convalescence after hand‐assisted laparoscopic donor nephrec‐
tomy and open donor nephrectomy.10 Two of 11 (18%) of hand‐as‐
sisted donors and 14 of 17 (82%) of open surgical donors reported 
minor residual effects from the operation (P = .0015), with a median 
follow‐up time of 35‐37 weeks, which included skin numbness, pain 
(usually with activity), and bulging at the incision. No studies have 
been performed on the development of CPSP following laparoscopic 
donor nephrectomy. CPSP can have a significant impact on health‐
related quality of life (HRQoL) and daily activities, as described in 
patients who underwent gastrointestinal surgery.11‐13 To our knowl‐
edge, the impact of CPSP after LDN on HRQoL is unknown. The aim 
of this cross‐sectional study was to explore the prevalence and risk 
factors of CPSP following LDN and its impact on the HRQoL.
2  | MATERIAL S AND METHODS
2.1 | Study design and patient population
A cross‐sectional study was performed among all living kidney donors 
who underwent a laparoscopic donor nephrectomy from January 2003 
through	December	2016	at	the	Radboud	University	Medical	Center	
(Radboudumc) Nijmegen. All types of laparoscopic procedures were 
included. The gold standard at the Radboudumc is a transperitoneal 
approach; in selected cases the surgeon chooses a hand‐assisted re‐
troperitoneoscopic approach (HARP) or if needed a conversion to a 
hand‐assisted laparoscopic donor nephrectomy (HALDN). Patients 
were eligible if they were able and willing to complete two question‐
naires regarding chronic pain problems related to their donor ne‐
phrectomy and their HRQoL. All patients were approached by phone 
or mail, and after their consent they received the questionnaires and 
were asked to complete and return them. The study was approved by 
the medical ethics committee of the Radboudumc (2017‐3110).
2.2 | Measures
The primary analysis consisted of the prevalence of CPSP following 
LDN. All included patients were asked if they still experienced pain 
related to their donor nephrectomy at the time that they were ap‐
proached for this study. Patients were considered to have CPSP if 
their answer was “yes.” In that case, the patients were asked to com‐
plete	the	Dutch	version	of	the	McGill	Pain	Questionnaire	(MPQ).14,15 
In addition, all included patients (with and without chronic pain) 
were	asked	to	fill	in	the	Dutch	version	of	the	RAND	Short	Form‐36	
Health	Status	Inventory	(RAND	SF‐36)	regarding	their	HRQoL.16,17
The	 MPQ	 is	 a	 validated	 multidimensional	 pain	 questionnaire	
designed to measure the quality and intensity of chronic pain.14,15 
The main section includes a list of 63 words, arranged in 20 cate‐
gories, describing different aspects of the experienced pain, each 
with three or four intensity levels. These words are divided into 
three major classes, that is, the sensory class describing the sensory 
quality of the pain; the affective class describing affective qualities 
of pain, including tension, fear, and autonomic reactions to the pain 
experience; and the evaluative class, describing the subjective over‐
all intensity of the pain. The quality of the pain is described by the 
chosen words specifically. Each word is accompanied with a value, 
based on its rank order within the word set of its category. The pain 
intensity is measured by the Number of Words Chosen (NWC) and 
the Pain Rating Index (PRI), which is the sum of the rank values cal‐
culated for each of the three classes separately and in total. A higher 
score indicates worse pain. The PRI scores are useful mainly as a ref‐
erence value to evaluate the effect of strategies to reduce CPSP. The 
MPQ	also	contains	a	Visual	Analogue	Scale	(VAS),	which	represents	
the pain severity at the time point of the questionnaire and is filled 
out	by	the	participant.	In	addition,	the	MPQ	includes	a	section	about	
localization, duration, and course of the pain, and a quality of life 
section. We did not include the quality of life section because we 
added a separate quality of life questionnaire.
The	 RAND	 Short	 Form‐36	Health	 Status	 Inventory	 (or	 RAND	
SF‐36)	is	a	validated	self‐administered	questionnaire	on	HRQoL.16,17 
It is composed of 36 questions, organized into eight multi‐item 
scales: physical functioning, bodily pain, role limitations due to phys‐
ical health problems, role limitations due to personal or emotional 
problems, general mental health, social functioning, energy/fatigue, 
and general health perceptions. The scores range from 0% to 100% 
per subscale, with higher scores indicating higher levels of function‐
ing or well‐being.
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We obtained preoperative data on quality of life from a selection 
of our patient group, provided by Wirken and colleagues, who per‐
formed a study on predonation cognition of potential living organ 
donors between 2010 and 2011.18 Therefore, we were able to com‐
pare preoperative and postoperative quality of life scores between 
patients with and without CPSP.
From	all	included	patients,	the	medical	records	were	reviewed	to	
obtain	information	on	their	age	during	surgery,	BMI,	and	relevant	his‐
tory, including previous abdominal surgery, preexisting pain problems 
(including spinal disc herniation and whiplash syndrome), and psychi‐
atric disorders. In addition, perioperative and postoperative data were 
retrieved, including side of nephrectomy, duration of surgery, conver‐
sion to hand‐assisted or open procedures, presence of severe early 
postoperative pain, analgesic use, postoperative complications, length 
of hospital stay, and readmissions within 3 months after surgery. We 
specified severe early postoperative pain as pain for which prolonged 
hospitalization (>5 days), prolonged opioid use (stated as continuation 
after discharge, which is not standard of care at our center), or an‐
esthesia consultation for adequate pain management was necessary.
2.3 | Statistical analysis
Due to the design of this study, no sample size calculation was per‐
formed. Continuous data were presented as mean and standard 
deviation (SD); categorical data were presented as number and per‐
centages. We used Student t‐test to compare normally distributed 
continuous variables and the chi‐square test for categorical variables. 
Binary logistic regression was performed to identify possible risk fac‐
tors for CPSP following LDN. All available variables were included in 
a univariate model. Variables with a significance level of P < .05 in the 
univariate analysis were included in the multivariate model. We did 
not perform data imputation, as the amount of missing data within our 
study	cohort	was	negligible.	For	all	 analyses,	 statistical	 significance	
was defined as P < .05. All statistical analyses were performed using 
Statistical	 Package	 for	 the	 Social	 Sciences	 (SPSS	 IBM	Statistics	 22;	
Armonk, NY).
3  | RESULTS
3.1 | Patient enrollment
A total of 862 patients underwent an LDN at Radboudumc Nijmegen 
in	the	period	from	January	2003	through	December	2016.	Forty‐nine	
patients were ineligible, since they passed away or because their con‐
tact details were lost. The remaining 813 patients were approached by 
phone or mail for written informed consent and participation between 
April 2017 and July 2017. We received responses from 542 patients 
(66.7%), of which 28 declined to provide informed consent and 2 were 
not able to complete the questionnaires because of illness. The remain‐
ing 512 adult living kidney donors signed informed consent and returned 
the	questionnaires.	The	patient	enrollment	is	depicted	in	Figure	1.
3.2 | Patient characteristics
The mean age ± SD at time of nephrectomy was 54.4 ± 9.9 years. 
Forty‐seven	percent	were	male	patients.	The	average	length	of	follow‐
up after surgery was 75.2 ± 44.3 months. Patient characteristics are 
presented in Table 1. We compared these patient characteristics with 
those of the nonrespondents group. The mean age of our respondents 
group was 6 years older, when compared to the nonrespondents group. 
There were no statistically significant differences in gender distribution 
and average length of follow‐up after surgery between the groups.
3.3 | Prevalence of CPSP
In the group of 512 living kidney donors, 29 patients (5.7%) reported 
the presence of chronic pain related to their donor nephrectomy. 
The highest prevalence (12.2%) was reported in the group with a 
F I G U R E  1  Flowchart	patient	
enrollment. LDN, laparoscopic donor 
nephrectomy
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follow‐up time of 3 to 24 months after surgery. The prevalence of 
CPSP	per	follow‐up	interval	is	presented	in	Figure	2.
3.4 | McGill Pain Questionnaire
Pain	 characteristics	 were	 evaluated	 by	 the	 MPQ,	 presented	 in	
Table 2. Pain unset was slow in 16 patients (55.2%) and acute in 10 
patients (34.5%). Various courses of pain were reported; most pa‐
tients (48.3%) experienced continuous pain, differing in severity, but 
37.9% of the patients described pain attacks with pain‐free inter‐
vals. The most reported pain localizations were the flank (25.0%), 
especially at the side of surgery, followed by the groin (18.2%) and 
suprapubic region (15.9%). Seven patients also experienced referred 
pain sensations. The mean general pain quantity, measured by a VAS, 
was a score of 20 (± 22) of 100.
The mean NCW was 6.2 of 20 words. Sensory descriptors were 
chosen more frequently than affective or evaluative terms. The most 
frequently selected words were nagging (n = 12; 41.4%) and stabbing 
(n = 11; 37.9%) in the sensory class; tiring (n = 6; 20.7%) in the affective 
class; and annoying (n = 16; 55.2%) in the evaluative class. The mean 
pain intensity measured by the total score of the PRI (PRI‐T was 10.21 
([SD 9.06; maximal possible score 63]). We performed subgroup anal‐
yses to assess the pain intensity (PRI‐T) in different types of patients; 
data are shown in Table 3. Pain intensity was higher in younger pa‐
tients than older patients (P	=	.01).	Gender,	BMI,	side	of	nephrectomy,	
and time since surgery were not of influence on the level of pain. We 
did not compare the different types of procedures, as the numbers of 
patients per group were too small to draw conclusions. Eight patients 
(27.6%) reported the use of analgesics because of their experienced 
pain, mostly acetaminophen or nonsteroidal antiinflammatory drugs; 
one patient reported the use of tramadol. None of the patients re‐
ported consultation of a pain specialist.
3.5 | Risk factors for the development of CPSP
The group of patients with CPSP comprised 10 male (34.5%) and 19 
female (65.5%) patients, with a mean age at time of nephrectomy 
of	52	±	9	years	and	a	BMI	of	26.8	±	4.4	kg/m².	Ninety‐three	percent	
TA B L E  1   Patient characteristics
Variables
All patients 
n = 512
Age during surgery (y) 54.4 ± 9.9
Gender	(male) 242 (47.3%)
BMI	(kg/m²) 26.2 ± 3.6
Side of nephrectomy (left) 433 (84.6%)
Type of procedure
Transperitoneal 457 (89.3%)
Retroperitoneoscopic 38 (7.4%)
Converted to hand‐assisted 11 (2.1%)
Converted to open surgery 6 (1.2%)
Length of follow‐up period n (%)
3 mo to <2 y 74 (14.5%)
2‐<4 y 96 (18.8%)
4‐<6 y 89 (17.4%)
6‐<8 y 76 (14.8%)
8‐<10 y 84 (16.4%)
10‐14 y 93 (18.2%)
Categorical variables are presented as n (%); continuous variables are 
presented as mean ± SD.
F I G U R E  2   Prevalence of CPSP per 
period of follow‐up time. CPSP, chronic 
postsurgical pain
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of the donors with CPSP donated their left kidney. Relevant his‐
tory included previous abdominal surgery (41.4%), preexisting pain 
problems (31.0%), and psychiatric disorders (6.9%). Ten patients 
(34.5%) had severe early postoperative pain. We performed binary 
logistic regression to identify predictive factors for CPSP following 
LDN, presented in Table 4. In the univariate analysis, severe early 
postoperative pain, previous abdominal surgery, preexisting pain 
problems, psychiatric history, and postoperative wound problems 
(ie, wound infection or hernia) had a significance level of P < .05. 
These variables were included in the multivariate analysis, in which 
the presence of severe early postoperative pain, previous abdominal 
surgery, and preexisting pain problems turned out to be predictors 
for the development of CPSP following LDN. The patients with CPSP 
localized at the back did not report preexisting backache problems.
Within all 29 patients with CPSP following their LDN, there were 
no negative outcomes of the recipients (in all cases a well‐function‐
ing graft within the first year). Therefore, we conclude that it is un‐
likely that our results were influenced by the recipients’ outcomes.
3.6 | Health‐related quality of life
The postoperative HRQoL of living kidney donors with CPSP was 
lower, when compared to donors without pain, as shown in Table 5. 
A major difference (32.6%) was seen with regard to role limitations 
TA B L E  2   Pain characteristics
McGill Pain Questionnaire components
Patients with 
CPSP n = 29
Start of pain
Acute 10 (34.5%)
Slowly 16 (55.2%)
Unknown 3 (10.3%)
Course of pain experience
Pain attacks, with pain‐free moments 11 (37.9%)
Continuous, differing in severity 14 (48.3%)
Continuous, stable severity 2 (6.9%)
VAS, general (0‐100) 20 ± 22
VAS, least pain (0‐100) 9 ± 11
VAS, worst pain (0‐100) 45 ± 28
Localization of pain
Flank 11 (25.0%)
Groin 8 (18.2%)
Suprapubic region 7 (15.9%)
Lower back 6 (13.6%)
Upper back 4 (9.1%)
Extremities 3 (6.8%)
Upper abdomen 2 (4.5%)
Other (scrotum, shoulders, head) 3 (6.8%)
Referred pain present 7 (24.1%)
Pain intensity
NWC‐S (0 to 12 words) 3.34 ± 2.91
NWC‐A (0 to 5 words) 0.90 ± 1.24
NWC‐E (0 to 3 words) 1.97 ± 1.18
NWC‐T (0 to 20 words) 6.21 ± 4.58
PRI‐S (0 to 36) 5.69 ± 5.63
PRI‐A (0 to 15) 1.28 ± 1.81
PRI‐E (0 to 12) 3.24 ± 2.59
PRI‐T (0 to 63) 10.21 ± 9.06
Categorical variables are presented as n (%); continuous variables are 
presented as mean ± SD.
CPSP, chronic postsurgical pain; VAS, visual analogue scale; NWC‐S, 
Number of Words Chosen of the sensory scale; NWC‐A, NWC of the 
affective scale; NWC‐E, NWC of the evaluative scale; NWC‐T, total 
NWC; PRI‐S, Pain‐Rating Index of the sensory scale; PRI‐A, PRI of the 
affective scale; PRI‐E, PRI of the evaluative scale; PRI‐T, total PRI.
TA B L E  3   PRI‐T subgroup analyses
Analysis Number of patients Mean PRI‐T P‐value
All patients 29 (of 512 patients) 10.21 ± 9.06 —
Gender .70
Male 10 9.30 ± 2.44
Female 19 10.68 ± 9.85
Age (y) .01
35‐<40 3 21.00 ± 14.18
40‐<45 6 14.17 ± 10.05
45‐<50 2 13.00 ± 16.97
50‐<55 4 8.50 ± 4.80
55‐<60 8 6.63 ± 5.90
60‐65 6 5.83 ± 4.49
BMI	(kg/m²) .08
<25 9 13.00 ± 10.59
25‐30 15 11.27 ± 8.27
>30 5 2.00 ± 2.12
Side of 
nephrectomy
.32
Left 27 (of 433 
procedures)
9.74 ± 8.92
Right 2 (of 79 procedures) 16.50 ± 12.02
Time since 
surgery (y)
.48
0‐<2 9 (of 74 patients) 10.22 ± 9.36
2‐<4 5 (of 96 patients) 8.20 ± 5.72
4‐<6 2 (of 89 patients) 13.50 ± 7.78
6‐<8 5 (of 76 patients) 11.20 ± 12.56
8‐<10 4 (of 84 patients) 16.50 ± 11.33
10‐14 4 (of 93 patients) 3.50 ± 1.00
Data were analyzed using analysis of variance (ANOVA). Variables are 
presented as mean ± standard deviation (SD).
Significant P‐values are in bold.
PRI‐T, total pain rating index (score 0‐63).
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due to physical health problems between donors without CPSP 
(89.7% ± 27.5%) and donors with CPSP (57.1% ± 47.1%) (P = .001). 
Furthermore,	on	the	scale	of	bodily	pain,	the	level	of	functioning	in	
the group with CPSP was 20% lower (72.1 ± 21.6) when compared 
to donors without CPSP (92.1 ± 16.0), (P < .001), and also a reduc‐
tion in energy of 18.3% was found in the patients with CPSP when 
compared to patients without CPSP (P < .001).
We obtained preoperative data by Wirken and colleagues on the 
HRQoL of 104 patients of our patient group, including 99 patients 
without CPSP and 5 patients with CPSP. The preoperative HRQoL 
scores were comparable between both groups, except for a sig‐
nificant lower score in the general mental health of the patients 
with CPSP when compared to patients without pain (respectively, 
72.8 ± 16.59 vs 85.78 ± 10.46, P = .01). Slight significant impair‐
ments were seen in the postoperative scores when compared to pre‐
operative scores in the group without CPSP, in physical functioning, 
general mental health, and energy level. The group of patients with 
CPSP showed severe deterioration after surgery in role limitations 
TA B L E  4   Univariate and multivariate regression analysis for CPSP following LDN
Parameters
Univariate analysis OR 
(95% CI) P‐value
Multivariate analysis OR 
(95% CI) P‐value
Age at time of surgery 0.975 (0.940‐1.011) .172 — —
Gender	(male) 0.569 (0.259‐1.250) .160 — —
BMI	(kg/m²) 1.046 (0.946‐1.157) .378 — —
Side of nephrectomy (left) 2.573 (0.599‐11.044) .204 — —
Duration of surgery 1.398 (0.730‐2.675) .312 — —
Converted to HARP, HALDN, or open 
procedure
2.311 (0.503‐10.626) .282 — —
Severe early postoperative pain 3.143 (1.402‐7.044) .005 2.470 (1.036‐5.888) .041
Length of hospital stay 1.054 (0.901‐1.234) .509 — —
Postoperative readmission 2.895 (0.617‐13.591) .178 — —
Time from surgery 0.992 (0.983‐1.001) .097 — —
Previous abdominal surgery 5.608 (2.542‐12.373) <.001 5.170 (2.278‐11.733) <.001
Preexisting pain problems 4.174 (1.798‐9.692) .001 3.326 (1.343‐8.237) .009
Psychiatric history 5.889 (1.135‐30.559) .035 3.983 (0.537‐29.522) .176
Postoperative wound infection or hernia 2.841 (1.018‐7.928) .046 1.210 (0.322‐4.551) .778
Significant P values are in bold.
CPSP, chronic postsurgical pain; HARP, hand‐assisted retroperitoneoscopic procedure; HALDN, hand‐assisted laparoscopic donor nephrectomy; 
LDN, laparoscopic donor nephrectomy; OR, odds ratio; 95% CI, 95% confidence interval.
RAND SF‐36 subscales 
(%)
Whole group 
n = 512
Patients with 
pain n = 29
Patients without 
pain n = 483 P‐value
Physical functioning 91.0 ± 15.4 80.7 ± 18.9 91.6 ± 14.9 .005
Role limitations due to 
physical health 
problems
87.9 ± 29.8 57.1 ± 47.1 89.7 ± 27.5 .001
Role limitations due to 
personal or emotional 
problems
93.6 ± 22.2 80.5 ± 38.3 94.4 ± 20.6 .063
Energy/fatigue 70.0 ± 19.2 52.8 ± 19.7 71.1 ± 18.7 <.001
General	mental	health 81.9 ± 14.2 71.4 ± 16.9 82.6 ± 13.8 .002
Social functioning 92.5 ± 16.1 83.6 ± 23.4 93.0 ± 15.4 .041
Bodily pain 90.9 ± 17.0 72.1 ± 21.6 92.1 ± 16.0 <.001
General	health	
perceptions
76.0 ± 18.6 63.2 ± 21.1 76.7 ± 18.1 <.001
Significant P values are in bold.
Variables are presented as mean ± SD.
HRQoL, health‐related quality of life.
TA B L E  5   HRQoL after donor 
nephrectomy	(RAND	SF‐36)	
     |  2831BRUINTJES ET al.
due to physical health problems, in bodily pain, and in physical 
functioning. Preoperative and postoperative HRQoL scores of both 
groups	are	depicted	in	Figure	3.
4  | DISCUSSION
This is the first study on the prevalence of CPSP following LDN. In 
this study, the mean prevalence of CPSP was 5.7% percent of 512 
donors who underwent a LDN at the Radboudumc, with a mean 
follow‐up of 6.3 (±3.7) years. The mean pain intensity measured by 
VAS was 20 on a scale of 0‐100 and by PRI‐T was 10 on a scale of 
0‐63. The multivariable regression analyses revealed that severe 
early postoperative pain, previous abdominal surgery, and preexist‐
ing pain problems are possible risk factors for the development of 
CPSP	following	LDN.	Furthermore,	we	found	an	impaired	quality	of	
life in patients with CPSP when compared to patients without CPSP, 
which is likely to be causally related.
Given	the	impaired	general	mental	health	scores	in	patients	who	
went on to develop CPSP, future research should pursue if impaired 
general mental health is a contraindication for kidney donation.
When compared to our findings, Owen et al observed re‐
markably higher incidences of postsurgical pain in open donor 
nephrectomy,9 which could be explained by the refinement in sur‐
gical techniques with less intraoperative nerve injury, which might 
lead to a decreased risk of CPSP following LDN. In accordance, a 
tumor nephrectomy is a more invasive procedure when compared 
to LDN: first, because kidney removal during tumor nephrectomy 
includes removal of the renal fascia, and second because of the use 
of	a	muscle‐splitting	McBurney	incision	instead	of	an	intermuscular	
Pfannenstiel incision. This could explain why we found fewer pa‐
tients with CPSP following LDN, when compared to patients who 
experienced CPSP following tumor nephrectomy.7,8 Our study pop‐
ulation included six patients in whom the surgery was converted to 
an open procedure. We performed additional analyses in which we 
excluded these patients (data not shown), which revealed no influ‐
ence on our outcomes.
Because of our study design, we were able to compare the prev‐
alence of CPSP in a large number of patients over different peri‐
ods of time since surgery, with a mean follow‐up time of 6.3 (± 3.7) 
years. In the prospective study by Owen and colleagues,9 all patients 
were approached 3 months after surgery. As shown in our patient 
group, the highest prevalence of CPSP was seen in this early period. 
However, we showed that the complaints of CPSP are also found 
over longer periods, even after more than 10 years.
This	 study	 has	 some	 limitations.	 First,	 due	 to	 the	 cross‐ 
sectional design, we could not assess the incidence of CPSP 
following LDN. The incidence of CPSP might be greater than 5.7%, 
as CPSP complaints may have resolved prior to the interview. 
There is also a slight risk of recall bias, as patients with a shorter 
follow‐up period might be more likely to attribute pain complaints 
to their donor nephrectomy, compared to patients in whom the 
surgery was more remote. Another limitation is that we received 
no response from 271 patients. There was a 6‐year difference 
with the respondents group and the nonrespondents group, which 
might have influenced our results. Due to the cross‐sectional de‐
sign, we could not perform baseline preoperative measurements 
on the HRQoL. However, we obtained preoperative data on the 
HRQoL of 20% of the included patients.18	The	MPQ	is	a	validated	
questionnaire. Despite this, there are different methods in the cal‐
culation of pain intensity scores, due to different language ver‐
sions and adjusted short‐form versions. Therefore, the PRI scores 
cannot	be	compared	between	versions	of	the	MPQ.	Nevertheless,	
our PRI scores can serve as reference values when using the Dutch 
language	version.	Furthermore,	the	MPQ	is	an	ideal	instrument	to	
evaluate the effects of strategies to reduce CPSP following LDN in 
future	studies.	Finally,,	due	to	the	small	number	of	events	(29	pa‐
tients with CPSP), there might be overestimation of the regression 
F I G U R E  3   HRQoL before and after 
LDN. HRQoL, health‐related quality  
of life; LDN, laparoscopic donor 
nephrectomy
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coefficients in our multivariate analysis. However, our findings are 
in line with known risk factors for CPSP in general.6 Prospective 
studies are needed for further investigation of risk factors for 
CPSP following LDN.
In conclusion, our unique data indicate that CPSP following LDN 
is a highly relevant issue. We found a substantial prevalence of CPSP 
of	5.7%	following	LDN.	Given	the	possible	association	between	the	
presence of CPSP and impaired HRQoL scores, living kidney donors 
should be well informed during the preoperative phase about the 
risk of CPSP. Prospective future studies should pursue strategies to 
reduce the incidence of CPSP after LDN.
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